Pacira BioSciences Statistics

Total Valuation

FRA:82P has a market cap or net worth of EUR 887.18 million. The enterprise value is 1.04 billion.

Market Cap	887.18M
Enterprise Value	1.04B

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	43.02M
Shares Outstanding	n/a
Shares Change (YoY)	-1.02%
Shares Change (QoQ)	-2.20%
Owned by Insiders (%)	1.03%
Owned by Institutions (%)	115.61%
Float	42.57M

Valuation Ratios

The trailing PE ratio is 48.55 and the forward PE ratio is 6.64.

PE Ratio	48.55
Forward PE	6.64
PS Ratio	1.45
PB Ratio	1.43
P/TBV Ratio	3.21
P/FCF Ratio	8.38
P/OCF Ratio	7.36
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.30, with an EV/FCF ratio of 9.83.

EV / Earnings	56.97
EV / Sales	1.69
EV / EBITDA	7.30
EV / EBIT	18.59
EV / FCF	9.83

Financial Position

The company has a current ratio of 5.26, with a Debt / Equity ratio of 0.58.

Current Ratio	5.26
Quick Ratio	3.38
Debt / Equity	0.58
Debt / EBITDA	2.56
Debt / FCF	3.42
Interest Coverage	3.57

Financial Efficiency

Return on equity (ROE) is 2.90% and return on invested capital (ROIC) is 3.20%.

Return on Equity (ROE)	2.90%
Return on Assets (ROA)	2.89%
Return on Invested Capital (ROIC)	3.20%
Return on Capital Employed (ROCE)	5.47%
Revenue Per Employee	774,298
Profits Per Employee	23,158
Employee Count	790
Asset Turnover	0.51
Inventory Turnover	1.83

Taxes

In the past 12 months, FRA:82P has paid 17.38 million in taxes.

Income Tax	17.38M
Effective Tax Rate	48.75%

Stock Price Statistics

The stock price has increased by +24.69% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+24.69%
50-Day Moving Average	19.75
200-Day Moving Average	21.08
Relative Strength Index (RSI)	51.52
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	11.60

Income Statement

In the last 12 months, FRA:82P had revenue of EUR 610.92 million and earned 18.27 million in profits. Earnings per share was 0.40.

Revenue	610.92M
Gross Profit	401.14M
Operating Income	55.52M
Pretax Income	35.65M
Net Income	18.27M
EBITDA	128.33M
EBIT	55.52M
Earnings Per Share (EPS)	0.40

Full Income Statement

Balance Sheet

The company has 209.95 million in cash and 362.49 million in debt, giving a net cash position of -152.54 million.

Cash & Cash Equivalents	209.95M
Total Debt	362.49M
Net Cash	-152.54M
Net Cash Per Share	n/a
Equity (Book Value)	619.80M
Book Value Per Share	14.43
Working Capital	388.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 120.55 million and capital expenditures -14.69 million, giving a free cash flow of 105.86 million.

Operating Cash Flow	120.55M
Capital Expenditures	-14.69M
Free Cash Flow	105.86M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 65.66%, with operating and profit margins of 9.09% and 2.99%.

Gross Margin	65.66%
Operating Margin	9.09%
Pretax Margin	5.84%
Profit Margin	2.99%
EBITDA Margin	21.01%
EBIT Margin	9.09%
FCF Margin	17.33%

Dividends & Yields

FRA:82P does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.02%
Shareholder Yield	1.02%
Earnings Yield	2.06%
FCF Yield	11.93%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:82P has an Altman Z-Score of 2.03 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.03
Piotroski F-Score	8